Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Name(s) of all antidepressants taken:

Age of patient when antidepressant(s) prescribed:

Was suicide attempted after taking antidepressant(s)?

Did attempted suicide result in death?

Was hospitalization or institutionalization required after taking antidepressant(s)?

Please describe hospitalization or institutionalization:

Age of patient when incident occurred:

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Eli Lilly In Storm Over Prozac Evidence

Dec 30, 2004 | Financial Times Eli Lilly, the US drug company, suppressed evidence that Prozac, its best-selling antidepressant, could cause behavioural disturbances, according to allegations published on Thursday in the British Medical Journal.

The US Food and Drug Administration says it would review confidential Lilly documents handed over by the BMJ, which received them this month from an anonymous source. The reports and memos appear to suggest Lilly officials knew in the 1980s that Prozac had troubling side-effects and sought to minimise their likely adverse effect on prescribing.

The journal says the documents “went missing” 10 years ago during a controversial product liability lawsuit filed on behalf of victims of Joseph Wesbecker, who shot eight colleagues dead, wounded 12 more and then killed himself. Mr Wesbecker had a history of depression and was prescribed Prozac a month before the shootings.

One document, a clinical trial review dated November 1988, stated that 38 per cent of patients treated with Prozac but only 19 per cent of those given a placebo “reported new activation”.

The FDA recently warned that Prozac and similar antidepressants could cause “activation” stimulating agitation, panic attacks and aggression.

In a statement defending its product, Lilly said: “Prozac has helped to significantly improve millions of lives. It is one of the most studied drugs in the history of medicine, and has beenprescribed for more than 50m people worldwide. The safety and efficiency of Prozac is well studied, well documented and well established.”

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo